Skip to main navigation Skip to search Skip to main content

MK-5172-061-00 A Phase III Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5 and GT6 Infection who are co-Infected with HIV

Project: Research

Project Details

StatusFinished
Effective start/end date07/14/14 → 07/13/18

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $62,089.80